Affordable Access

Allogeneic bone marrow transplantation in acute myeloid and lymphocytic leukemia.

Authors
Type
Published Article
Journal
Current Opinion in Oncology
1040-8746
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
5
Issue
2
Pages
255–261
Identifiers
PMID: 8457611
Source
Medline
License
Unknown

Abstract

Allogeneic bone marrow transplantation is an accepted therapy for acute leukemia, with an increased rate of long-term survival and possible cure. Unfortunately, it can be given only when an HLA-identical donor is found. For this reason, large international registries containing normal HLA-typed volunteer marrow donors have been established. Although preliminary, results are encouraging. Approaches using stem cell purification and expansion, fetal and neonatal cells, and new immunosuppressive agents are currently under investigation.

Statistics

Seen <100 times